Of the many subsets of healthcare, nowhere will you find more exuberance over AI’s emergence, than in drug development. Courted by its lofty promise to solve pharma’s top two challenges, AI can potentially shorten the drug development pipeline and cut expenses by over 50%. Biopharma, known for massive operational costs to bring a drug to […]
